Medicare Enrolled
Dr. Ivor Percent, M.D.
Hematology · Port Charlotte, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Percent from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Percent?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Percent
Dr. Ivor Percent is a hematology specialist in Port Charlotte, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Percent performed 320,884 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Percent received a total of $25,254 from 97 pharmaceutical and/or device companies across 874 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Percent is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 7% volume in FL
$25,254 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗320,884
Medicare services
Top 7% in FL for hematology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
74,970 | $0 | $4 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
28,200 | $0 | $5 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
22,500 | $1 | $3 |
| Filgrastim injection, 1 microgram An injection of filgrastim, a medication that stimulates the production of white blood cells. This code specifically covers the brand-name drug and excludes biosimilar versions. |
21,660 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 15,800 | $43 | $137 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
14,794 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 14,690 | $1 | $5 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
13,860 | $0 | $2 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
12,500 | $0 | $12 |
| Paclitaxel chemotherapy injection | 11,346 | $0 | $2 |
| Nivolumab injection (Opdivo) | 11,320 | $24 | $72 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
10,440 | $38 | $110 |
| Denosumab injection (Prolia/Xgeva) | 9,300 | $18 | $51 |
| Injection, mepolizumab, 1 mg | 9,100 | $23 | $72 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
7,000 | $0 | $4 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
5,806 | $36 | $108 |
| Omalizumab injection (Xolair) for asthma/allergy | 5,190 | $30 | $95 |
| Injection, durvalumab, 10 mg | 5,002 | $62 | $191 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,568 | $0 | $3 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
3,168 | $26 | $116 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
3,125 | $8 | $9 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
3,086 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,780 | $1 | $28 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,340 | $10 | $69 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,305 | $95 | $339 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,085 | $12 | $61 |
| Anti-nausea injection (ondansetron/Zofran) | 952 | $0 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
759 | $63 | $239 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
650 | $27 | $124 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
596 | $97 | $378 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
578 | $47 | $189 |
| Injection, leucovorin calcium, per 50 mg | 527 | $3 | $12 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
452 | $2 | $41 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
420 | $1 | $6 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
406 | $2 | $7 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
307 | $1 | $3 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
298 | $17 | $59 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
293 | $4 | $10 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
278 | $1 | $2 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
226 | $3 | $11 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
211 | $21 | $79 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
187 | $10 | $42 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
186 | $15 | $56 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
169 | $2 | $7 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
164 | $54 | $206 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
154 | $49 | $178 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
121 | $124 | $453 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
117 | $21 | $84 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
117 | $28 | $156 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
81 | $23 | $156 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
72 | $2 | $8 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
72 | $139 | $474 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 72 | $135 | $562 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
66 | $42 | $170 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
59 | $4 | $15 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
52 | $25 | $89 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
44 | $120 | $637 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
43 | $5 | $20 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
42 | $15 | $56 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
36 | $65 | $277 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
30 | $1 | $7 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
28 | $4 | $15 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
25 | $63 | $197 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
24 | $126 | $467 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $92 | $377 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $137 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
33.0% high complexity
64.0% medium
3.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,254
Total received (2018-2024)
Avg $3,608/year across 7 years
Top 18% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
97
Companies
874
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,420
2023
$3,033
2022
$3,047
2021
$9,139
2020
$1,795
2019
$2,812
2018
$2,008
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$246
Merck Sharp & Dohme LLC
$232
PFIZER INC.
$186
E.R. Squibb & Sons, L.L.C.
$184
Daiichi Sankyo Inc.
$175
Gilead Sciences, Inc.
$170
Janssen Biotech, Inc.
$157
Incyte Corporation
$142
GlaxoSmithKline, LLC.
$141
Takeda Pharmaceuticals U.S.A., Inc.
$116
Celgene Corporation
$104
ABBVIE INC.
$98
Lilly USA, LLC
$92
ARRAY BIOPHARMA INC
$83
Exelixis Inc.
$78
AstraZeneca Pharmaceuticals LP
$76
JAZZ PHARMACEUTICALS INC.
$76
Astellas Pharma US Inc
$71
BeiGene USA, Inc.
$71
Eisai Inc.
$64
Rigel Pharmaceuticals, Inc.
$63
Bayer Healthcare Pharmaceuticals Inc.
$61
SOBI, INC
$59
Mirati Therapeutics, Inc.
$55
Pharmacosmos Therapeutics Inc.
$49
Alnylam Pharmaceuticals Inc.
$45
EMD Serono, Inc.
$39
Genentech USA, Inc.
$37
PUMA BIOTECHNOLOGY, INC.
$33
Dendreon Pharmaceuticals LLC
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Stemline Therapeutics Inc.
$29
Regeneron Healthcare Solutions, Inc.
$28
SpringWorks Therapeutics, Inc.
$26
Adaptive Biotechnologies Corporation
$24
Iovance Biotherapeutics, Inc.
$24
PharmaEssentia USA Corporation
$24
Kite Pharma, Inc.
$23
ADC Therapeutics America, Inc.
$21
Acrotech Biopharma Inc.
$19
Cumberland Pharmaceuticals, Inc.
$19
SERVIER PHARMACEUTICALS LLC
$19
Epizyme, Inc.
$18
Genmab U.S., Inc.
$17
Sumitomo Pharma America, Inc.
$16
Blueprint Medicines Corporation
$16
GENZYME CORPORATION
$15
Alexion Pharmaceuticals, Inc.
$15
Top 3 companies account for 19.4% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim International GmbH
$8,149
Novartis Pharmaceuticals Corporation
$1,263
F. Hoffmann-La Roche AG
$1,185
E.R. Squibb & Sons, L.L.C.
$1,181
PFIZER INC.
$678
Janssen Biotech, Inc.
$665
Merck Sharp & Dohme LLC
$662
Genentech USA, Inc.
$602
Lilly USA, LLC
$596
Incyte Corporation
$525
Gilead Sciences, Inc.
$519
Merck Sharp & Dohme Corporation
$499
GENZYME CORPORATION
$498
Celgene Corporation
$487
Daiichi Sankyo Inc.
$462
Astellas Pharma US Inc
$446
Seagen Inc.
$383
Exelixis Inc.
$371
BeiGene USA, Inc.
$318
AstraZeneca Pharmaceuticals LP
$302
Amgen Inc.
$293
GlaxoSmithKline, LLC.
$278
Boehringer Ingelheim Pharma GmbH & Co.KG
$258
Regeneron Healthcare Solutions, Inc.
$255
Bayer HealthCare Pharmaceuticals Inc.
$198
ARRAY BIOPHARMA INC
$189
ABBVIE INC.
$158
Takeda Pharmaceuticals U.S.A., Inc.
$146
Ethicon Inc.
$145
Boehringer Ingelheim Pharmaceuticals, Inc.
$133
Puma Biotechnology, Inc.
$131
JAZZ PHARMACEUTICALS INC.
$130
Deciphera Pharmaceuticals Inc.
$124
Mirati Therapeutics, Inc.
$111
Kite Pharma, Inc.
$105
Rigel Pharmaceuticals, Inc.
$100
Karyopharm Therapeutics Inc.
$100
Intuitive Surgical, Inc.
$96
Eisai Inc.
$94
AbbVie Inc.
$92
Seattle Genetics, Inc.
$90
PharmaEssentia USA Corporation
$89
Dendreon Pharmaceuticals LLC
$84
SERVIER PHARMACEUTICALS LLC
$84
EMD Serono, Inc.
$82
Stemline Therapeutics Inc.
$79
Pharmacyclics LLC, An AbbVie Company
$78
EISAI INC.
$76
Bayer Healthcare Pharmaceuticals Inc.
$76
SANOFI-AVENTIS U.S. LLC
$76
Myovant Sciences Inc.
$73
TerSera Therapeutics LLC
$70
ADC Therapeutics America, Inc.
$70
Taiho Oncology, Inc.
$69
Blueprint Medicines Corporation
$66
Pharmacosmos Therapeutics Inc.
$63
Dova Pharmaceuticals
$61
Alnylam Pharmaceuticals Inc.
$60
SOBI, INC
$59
PUMA BIOTECHNOLOGY, INC.
$50
Pharmacyclics LLC, an AbbVie Company
$50
AMAG Pharmaceuticals, Inc.
$49
Foundation Medicine, Inc.
$43
Acrotech Biopharma Inc.
$41
Kyowa Kirin, Inc.
$38
Sobi, Inc
$35
Sumitomo Pharma America, Inc.
$32
Alexion Pharmaceuticals, Inc.
$32
G1 Therapeutics, Inc.
$31
CTI BioPharma Corp.
$30
Sirtex Medical Inc
$26
SpringWorks Therapeutics, Inc.
$26
Telix Pharmaceuticals
$25
NanoString Technologies, Inc.
$24
Adaptive Biotechnologies Corporation
$24
Iovance Biotherapeutics, Inc.
$24
Sun Pharmaceutical Industries Inc.
$24
GE HealthCare
$22
AbbVie, Inc.
$22
Secura Bio, Inc.
$21
MorphoSys, US Inc.
$20
Cumberland Pharmaceuticals, Inc.
$19
Epizyme, Inc.
$18
Genmab U.S., Inc.
$17
Immunomedics, Inc.
$16
Aveo Pharmaceuticals, Inc.
$16
Ipsen Biopharmaceuticals, Inc
$16
Epizyme, Inc.,
$16
Helsinn Therapeutics (U.S.), Inc.
$16
Sysmex Inostics Inc
$15
Agios Pharmaceuticals, Inc.
$15
Clovis Oncology, Inc.
$15
Acrotech Biopharma LLC
$14
Horizon Therapeutics plc
$13
Teva Pharmaceuticals USA, Inc.
$12
Heron Therapeutics, Inc.
$12
Veracyte, Inc.
$1
Top 3 companies account for 42.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Amtagvi · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Monarch Platform · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETACRIT · RETEVMO · RYBREVANT · RYDAPT · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xolair · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
10
County median income
$66,154
Nearest hospital to ZIP centroid (approximate)
Adventhealth Port Charlotte
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Percent is a mixed practice specialist, with above-average Medicare volume (top 7% in FL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Percent experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Percent performed 74,970 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Percent receive payments from pharmaceutical companies?
Yes. Dr. Percent received a total of $25,254 from 97 companies across 874 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Percent's costs compare to other hematologists in Port Charlotte?
Dr. Percent's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Percent) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Port Charlotte
Browse hematologists in Port Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Boehringer Ingelheim International GmbH Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim International GmbH.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
F. Hoffmann-La Roche AG Payments to Doctors
See all physicians who received payments from F. Hoffmann-La Roche AG.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology